CHCR logo

Advanzeon Solutions, Inc. (CHCR) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Advanzeon Solutions, Inc. (CHCR), Healthcare sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 46/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
46/100 AI Puanı

Advanzeon Solutions, Inc. (CHCR) Sağlık ve Boru Hattı Genel Bakışı

CEOClark A. Marcus
Çalışanlar2
MerkezTampa, US
Halka Arz Yılı1975
SektörHealthcare

Advanzeon Solutions, Inc. operates in the healthcare sector, focusing on sleep apnea program administration through its SleepMaster Solutions. Currently trading on the OTC market after a Chapter 11 filing, the company faces challenges in a competitive medical care facilities landscape.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Investing in Advanzeon Solutions, Inc. (CHCR) presents significant risks due to its OTC market listing and recent Chapter 11 bankruptcy filing in 2020. The company's reliance on the SleepMaster Solutions program for revenue makes it vulnerable to market shifts and competition. With a market capitalization of $0.00B and a beta of 1.24, CHCR exhibits high volatility. Potential investors should closely monitor the company's restructuring efforts and ability to regain financial stability. Growth catalysts are uncertain, and the company's future depends on successfully navigating its bankruptcy proceedings and re-establishing a competitive position in the healthcare sector.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Advanzeon Solutions, Inc. operates the SleepMaster Solutions sleep apnea program.
  • The company filed for Chapter 11 bankruptcy on September 7, 2020.
  • CHCR trades on the OTC market, indicating higher risk and lower liquidity.
  • The company's market capitalization is $0.00B, reflecting its distressed financial state.
  • The company's beta is 1.24, indicating higher volatility than the market.

Rakipler & Benzerleri

Güçlü Yönler

  • Specialized SleepMaster Solutions program.
  • Experience in sleep apnea program administration.
  • Established presence in the healthcare sector.
  • Focus on a specific medical condition.

Zayıflıklar

  • Recent Chapter 11 bankruptcy filing.
  • OTC market listing indicating higher risk.
  • Limited market capitalization.
  • Reliance on a single product line.

Katalizörler

  • Upcoming: Successful restructuring and emergence from Chapter 11 bankruptcy could restore investor confidence.
  • Ongoing: Expansion of the SleepMaster Solutions program into new markets could drive revenue growth.
  • Ongoing: Strategic partnerships with healthcare providers could enhance market penetration.

Riskler

  • Ongoing: Financial instability due to Chapter 11 bankruptcy.
  • Potential: Intense competition in the medical care facilities industry.
  • Potential: Regulatory changes and reimbursement pressures.
  • Ongoing: Limited liquidity and high volatility due to OTC market listing.
  • Potential: Dependence on a single product line (SleepMaster Solutions).

Büyüme Fırsatları

  • Expansion of Sleep Apnea Program: Advanzeon could focus on expanding its SleepMaster Solutions program by targeting new geographic markets and patient demographics. The global sleep apnea devices market is projected to reach $5.2 billion by 2027, offering a substantial growth opportunity. Success depends on effective marketing, strategic partnerships, and demonstrating superior patient outcomes.
  • Telehealth Integration: Integrating telehealth services into the SleepMaster Solutions program could enhance accessibility and convenience for patients, particularly in remote areas. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing demand for remote healthcare solutions. This integration could improve patient engagement and reduce operational costs.
  • Strategic Partnerships: Forming strategic alliances with healthcare providers, insurance companies, and sleep clinics could expand Advanzeon's reach and market penetration. Partnerships can provide access to new patient referrals, distribution channels, and reimbursement opportunities. Successful partnerships require alignment of goals, clear communication, and mutual benefit.
  • Product Diversification: Diversifying beyond sleep apnea treatment into related respiratory care services could broaden Advanzeon's revenue streams and reduce its reliance on a single product line. This could include offering diagnostic services, respiratory therapy, and home healthcare solutions. Diversification requires careful market research, investment in new technologies, and skilled personnel.
  • Cost Optimization: Implementing cost-saving measures and streamlining operations could improve Advanzeon's financial performance and enhance its competitiveness. This includes optimizing supply chain management, reducing administrative expenses, and improving operational efficiency. Cost optimization is crucial for companies facing financial challenges and can improve profitability and cash flow.

Fırsatlar

  • Expansion into new geographic markets.
  • Integration of telehealth services.
  • Strategic partnerships with healthcare providers.
  • Diversification into related respiratory care services.

Tehditler

  • Intense competition in the medical care facilities industry.
  • Regulatory changes and reimbursement pressures.
  • Potential for product obsolescence.
  • Economic downturn affecting patient affordability.

Rekabet Avantajları

  • Proprietary SleepMaster Solutions program.
  • Established relationships with healthcare providers.
  • Experience in sleep apnea program administration.
  • Focus on specialized care services.

CHCR Hakkında

Advanzeon Solutions, Inc., formerly known as Comprehensive Care Corporation, was established in 1969 and rebranded in January 2014. Headquartered in Tampa, Florida, the company operates through its subsidiary, Pharmacy Value Management Solutions, Inc., which administers and manages the SleepMaster Solutions program, a sleep apnea treatment service. Advanzeon's core business revolves around providing solutions for individuals suffering from sleep apnea, a prevalent condition affecting millions. However, on September 7, 2020, Advanzeon Solutions, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, impacting its operational and financial stability. The company's long-term viability hinges on its ability to restructure and regain market confidence while navigating the competitive landscape of the medical care facilities industry.

Ne Yaparlar

  • Administers and operates the SleepMaster Solutions sleep apnea program.
  • Provides solutions for individuals suffering from sleep apnea.
  • Operates through its subsidiary, Pharmacy Value Management Solutions, Inc.
  • Offers sleep apnea treatment services.
  • Focuses on managing sleep apnea programs.
  • Aims to improve the quality of life for sleep apnea patients.

İş Modeli

  • Generates revenue through the SleepMaster Solutions program.
  • Provides sleep apnea treatment services to patients.
  • Partners with healthcare providers and insurance companies.
  • Focuses on program administration and management.

Sektör Bağlamı

Advanzeon Solutions, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is characterized by increasing demand for specialized care services, including sleep apnea treatment. However, the competitive landscape is intense, with established players and emerging technologies vying for market share. Advanzeon's position is challenged by its recent bankruptcy filing and the need to restructure its operations. The industry is also subject to regulatory changes and reimbursement pressures, further impacting the company's prospects.

Kilit Müşteriler

  • Individuals suffering from sleep apnea.
  • Healthcare providers and sleep clinics.
  • Insurance companies covering sleep apnea treatment.
  • Patients seeking solutions for sleep-related breathing disorders.
AI Güveni: 69% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Advanzeon Solutions, Inc. (CHCR) hisse senedi fiyatı: Price data unavailable

Son Haberler

CHCR için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CHCR için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CHCR için Wall Street fiyat hedefi analizi.

MoonshotScore

46/100

Bu puan ne anlama geliyor?

MoonshotScore, CHCR'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Clark A. Marcus

Managing Director

Clark A. Marcus serves as the Managing Director of Advanzeon Solutions, Inc. His role involves overseeing the company's operations and strategic direction. Information on his prior experience and education is not available. As the managing director, he is responsible for the overall performance and management of the company, particularly during its restructuring phase following the Chapter 11 filing.

Sicil: Due to limited information available, Clark A. Marcus's specific achievements and strategic decisions at Advanzeon Solutions, Inc. are unknown. His tenure is marked by the company's Chapter 11 bankruptcy filing in 2020, indicating significant challenges during his leadership. Evaluating his long-term impact requires further information on the company's restructuring efforts and future performance.

CHCR OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Advanzeon Solutions, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may be undergoing financial distress or restructuring. Unlike NYSE or NASDAQ-listed companies, OTC Other stocks generally have less stringent listing requirements, leading to increased risk and volatility for investors. This tier signifies a higher level of caution is warranted due to the potential for limited information and regulatory oversight.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Trading volume for CHCR is likely to be low due to its OTC Other listing and financial challenges. Bid-ask spreads are expected to be wide, reflecting the limited liquidity and higher risk associated with the stock. Trading may be difficult, with potential for price volatility and limited order execution. Investors should exercise caution and be prepared for potential challenges in buying or selling shares.
OTC Risk Faktörleri:
  • Limited financial disclosure due to OTC Other listing.
  • High price volatility and potential for manipulation.
  • Risk of delisting or trading suspension.
  • Limited liquidity and wide bid-ask spreads.
  • Potential for fraud or mismanagement.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Assess the company's management team and their track record.
  • Evaluate the company's business model and competitive landscape.
  • Review the company's legal and regulatory compliance.
  • Analyze the company's debt and cash flow situation.
  • Monitor news and press releases for updates on the company's restructuring efforts.
  • Consult with a financial advisor before investing.
Meşruiyet Sinyalleri:
  • Established history since 1969.
  • Operation of the SleepMaster Solutions program.
  • Presence in the healthcare sector.
  • Continued efforts to restructure after bankruptcy.
  • Existence of a subsidiary, Pharmacy Value Management Solutions, Inc.

CHCR Hakkında Sıkça Sorulan Sorular

CHCR için değerlendirilmesi gereken temel faktörler nelerdir?

Advanzeon Solutions, Inc. (CHCR) şu anda yapay zeka skoru 46/100, düşük puanı gösteriyor. Temel güçlü yan: Specialized SleepMaster Solutions program.. İzlenmesi gereken birincil risk: Ongoing: Financial instability due to Chapter 11 bankruptcy.. Bu bir finansal tavsiye değildir.

CHCR MoonshotScore'u nedir?

CHCR şu anda MoonshotScore'da 46/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CHCR verileri ne sıklıkla güncellenir?

CHCR fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CHCR hakkında ne diyor?

CHCR için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CHCR'a yatırım yapmanın riskleri nelerdir?

CHCR için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Financial instability due to Chapter 11 bankruptcy.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CHCR'ın P/E oranı nedir?

CHCR için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CHCR'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CHCR aşırı değerli mi, yoksa düşük değerli mi?

Advanzeon Solutions, Inc. (CHCR)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CHCR'ın temettü verimi nedir?

Advanzeon Solutions, Inc. (CHCR) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is limited due to the company's OTC listing and bankruptcy filing.
  • Financial data may not be readily available or reliable.
  • Analyst coverage is unlikely given the company's financial condition.
Veri Kaynakları

Popüler Hisseler